Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
APX-3330 | Small molecule | cancer | DNA-(apurinic or apyrimidinic site) lyase inhibitor | 1.0 | Completed | ClinicalTrials |
APX-3330 | Small molecule | diabetic macular edema | DNA-(apurinic or apyrimidinic site) lyase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
APX-3330 | Small molecule | proliferative diabetic retinopathy | DNA-(apurinic or apyrimidinic site) lyase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |